GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of small win: A1c stopped being a problem at week 50 — 25 comments in the full submission. View in context.
589
c/t2dglp1·submitted 5 months ago by u/bianca_dziedzic

small win: A1c stopped being a problem at week 50

Questionbranch of 4 comments

Posting this because I searched for it and got nothing useful. Setup: 5mg, week 77, injection-site soreness present but not ruining anything. I changed exactly one variable — metformin — and tracked it for 5 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted…

Read the full submission and all 25 comments →

This branch

4 comments, started 5 months ago
u/swirl_dont_shakereconstitution42 points·5 months ago

hypoglycaemia risk when stacked with A1c

replysharereportpermalink
u/hana_lehtinen9 points·5 months ago

the eGFR change is the signal

replysharereportpermalink
u/arne_amankwah3 points·5 months ago

Strongly agree. A1c matters as much as weight.

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/t2dglp1

Type 2 diabetes as the original indication: A1c trajectories, CGM traces, hypoglycaemia risk when stacked with sulfonylureas or insulin, metformin combinations, and why the weight-loss conversation sometimes drowns out the glycaemic one.

36kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/t2dglp1 rules
  1. Insulin and sulfonylurea interactions are a real hypo risk. Do not hand-wave them.
  2. Post A1c with units and the assay date.
  3. No medication-stopping advice. Ever.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.